eXoZymes Launches BioClick with $300K NIH Grant
Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) – a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals –...
Author : GlobeNewswire
First Federal Bank Awards $27.5K Grant to Habitat for Humanity
First Federal Savings Bank, a member bank of the Federal Home Loan Bank of Indianapolis (FHLBank Indianapolis), awarded Habitat for Humanity $27,500 in grant funds...
Harvard Bioscience Announces CFO Transition
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of Jennifer Cote, the Company’s Chief Financial Officer and Treasurer. Ms. Cote’s resignation will...
William Connelly Named Future SocGen Chairman Starting 2026
WILLIAM CONNELLY, FUTURE SOCIETE GENERALE CHAIRMAN OF THE BOARD OF DIRECTORS, STARTING MAY 2026 During its session on 10 April 2025, the Societe Generale Board of...
argenx Gets FDA Nod for VYVGART Self-Injection Prefilled Syringe
argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that...
JFK Law Expands Nationally with Nadir André and Team
JFK Law LLP (“JFK Law”) is pleased to announce that Nadir André has joined the firm as a Partner, alongside associates Lauren Daniel and Isabelle...
Basel Medical to Acquire Bethesda, Expand in SE Asia Healthcare
Basel Medical Group Ltd (Nasdaq: BMGL), today announced the signing of a definitive agreement by its subsidiary Basel Medical Group Pte. Ltd. to acquire Bethesda...
John Mattone Global Expands Partnerships in Exec Coaching
John Mattone Global (JMG), a recognized leader in executive coaching and leadership development, has announced a series of new strategic partnerships with top-tier organizations across...
Inbiome’s IVDR-Certified Test IDs Bacteria in 5 Hours
Inbiome Shatters Diagnostic Delays: IVDR-Certified Platform IDs Bacteria in 5 Hours Across EU Hospitals Inbiome, a pioneering Dutch diagnostics company, announced today that it has received...
Vantage Biosciences Begins Phase 2 Trial of Oral VX-01 for NPDR
Vantage Biosciences, a clinical stage biotechnology company advancing innovative therapies for diabetic eye diseases, today announced that the first patient has been successfully dosed in...